CervAlign Anterior Cervical Plate System-Cervalign, 3 Level, 48mm Material Number: 66-348 - Product Usage: intended for anterior cervical fixation (C2-C7) for the following conditions: degenerative disc disease (DDD) defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies, spondylolisthesis, trauma (i.e. fracture or dislocation), spinal stenosis, deformities or curvatures (i.e. scoliosis, kyphosis, and/or lordosis), tumor, pseudathrosis, and failed previous fusion).
Published March 17, 2021 · Recall initiated: January 15, 2021
Summary
FDA records medical device Class II recall Z-1222-2021, published March 17, 2021 and initiated January 15, 2021. Recalling firm: RTI Surgical, Inc. (dba Pioneer Surgical Technology, Inc.); Status: Ongoing; Lot: Batch Number: 333019 333020 338839 341491 346885 351526 354405 359842 359843 363443 364532 369362 370404 377837 379929 385416. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Locking mechanism has been observed to disassociate either intraoperatively or postoperatively resulting in replacement/revision
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- RTI Surgical, Inc. (dba Pioneer Surgical Technology, Inc.)
- Distributor
- US Nationwide distribution.
- Lot
- Batch Number: 333019 333020 338839 341491 346885 351526 354405 359842 359843 363443 364532 369362 370404 377837 379929 385416
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDASpironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottlesMarch 24, 2021
- FDAPhenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-DoseMarch 24, 2021
- FDACervAlign Anterior Cervical Plate System-Cervalign, 2Level, 38mm Material Number: 66-238 - Product Usage:March 17, 2021
- FDACervAlign Anterior Cervical Plate System-Cervalign, 3Level, 63mm Material Number: 66-363 - Product Usage:March 17, 2021
- FDADimension Vista HDLC - colorimetric method, lipoproteins - Product Usage: used as an aid in the diagnosis ofMarch 17, 2021
- FDAHu***CHOCOLATE-COVERED HUNKS SOUR GOLDENBERRIES***Net Wt. 4 oz (113g); packaged in a black bag; DistributedMarch 17, 2021
Questions about this recall
Was CervAlign Anterior Cervical Plate System-Cervalign, 3 Level, 48mm Material Number: 66-348 - Product Usage: intended for anterior cervical fixation (C2-C7) for the following conditions: degenerative disc disease (DDD) defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies, spondylolisthesis, trauma (i.e. fracture or dislocation), spinal stenosis, deformities or curvatures (i.e. scoliosis, kyphosis, and/or lordosis), tumor, pseudathrosis, and failed previous fusion). recalled?
Yes. FDA published recall Z-1222-2021 on March 17, 2021. Reported hazard: Locking mechanism has been observed to disassociate either intraoperatively or postoperatively resulting in replacement/revision
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit